Vesugen powder is a laboratory-grade synthetic peptide composed of the amino acid sequence Lys-Glu-Asp (KED). The compound is produced through solid-phase peptide synthesis followed by purification using high-performance liquid chromatography (HPLC). After purification, the material undergoes lyophilization to obtain a stable white powder form suitable for storage, transportation, and experimental preparation.
Short regulatory peptides with defined amino acid sequences are frequently investigated in biochemical and molecular biology research. Their compact structure and predictable molecular characteristics make them suitable for experimental models exploring peptide-associated molecular recognition processes and cellular regulatory pathways.
Shaanxi Medibridge Biotech Co., Ltd. provides research peptides for laboratories, academic institutions, and biotechnology organizations worldwide. The company maintains standardized peptide synthesis procedures and consistent batch production to ensure reliable supply for research environments.
COA
|
|
||
|
Product Name |
CAS Number |
Batch Number |
|
Vesugen powder |
N/A |
MB2601261030 |
|
Manufacturer Date |
Analysis Date |
Expiry Date |
|
2026-01-26 |
2026-01-27 |
2028-01-25 |
|
Sample Qty Base |
Packing |
Test Method |
|
1.96KGS |
10GS/bottle |
HPLC |
|
Item |
Standard |
Results |
|
Appearance |
White lyophilized powder |
Conforms |
|
Identification (HPLC) |
Retention time consistent with reference standard |
Conforms |
|
Peptide Sequence |
Lys-Glu-Asp (KED) |
Conforms |
|
Molecular Formula |
C15H26N4O8 |
Conforms |
|
Molecular Weight |
390.39 |
Conforms |
|
Purity (HPLC) |
NLT 98.0% |
98.59% |
|
Solubility |
Soluble in water |
Conforms |
|
Water Content (Karl Fischer) |
NMT 5.0% |
2.19% |
|
Acetate Content |
NMT 12.0% |
6.07% |
|
Heavy Metals |
NMT 10 ppm |
Conforms |
|
Related Substances |
NMT 2.0% |
Conforms |
|
Microbial Limits |
Complies with laboratory reagent standards |
Conforms |
|
Storage |
Store in cool & dry place. keep away from strong light and heat |
|
|
Conclusion |
The batch conforms to the IN-HOUSE standard |
|
|
|
||
Tripeptide Structural Profile
This peptide is defined by a compact tripeptide structure consisting of lysine, glutamic acid, and aspartic acid (KED). With only three amino acids, it represents a minimal regulatory sequence often used in peptide signaling research.
Short peptides in this size range are frequently studied because their limited structural complexity allows researchers to examine how specific amino acid combinations influence molecular recognition and intracellular signaling. Their small molecular size may also facilitate movement across cellular membranes, enabling interaction with intracellular environments.
Within experimental peptide science, minimal sequences like KED are commonly explored as models for understanding sequence-dependent regulatory activity, particularly in studies focused on peptide–DNA interaction hypotheses and intracellular signaling dynamics.
Vascular Endothelium Research Model
Laboratory models investigating endothelial biology often use small regulatory peptides to explore how molecular signals influence cellular stability and intercellular communication. These studies typically examine pathways associated with oxidative balance, nitric oxide signaling, and endothelial barrier regulation.
By studying peptide interactions within endothelial systems, researchers aim to better understand how molecular signals contribute to vascular coordination and endothelial cell function under controlled experimental conditions.
MKI67 Gene Interaction Studies
Research into short regulatory peptides has also explored their possible interactions with genomic regulatory regions. One gene frequently examined in cellular studies is MKI67, which encodes the Ki-67 protein, a widely used indicator of cellular proliferation.
Experimental models have proposed that certain peptide sequences may associate with DNA regulatory regions or chromatin structures, potentially influencing transcriptional activity. Such interactions are of interest because they provide a framework for studying how small peptides might participate in gene regulation.
Investigations involving proliferation-related genes like MKI67 therefore serve as useful systems for examining peptide-mediated gene expression models and potential epigenetic signaling mechanisms.
Microcirculation & Vascular Aging Models
Experimental microvascular models are often used to examine how endothelial cells maintain capillary networks, regulate vessel elasticity, and adapt to environmental stress. Researchers also study how these systems change over time as part of broader vascular aging investigations.
Short peptide regulators are sometimes incorporated into these studies to explore how molecular signals participate in maintaining microvascular organization, endothelial turnover, and cellular communication within vascular networks.
Research Applications
In laboratory research, short regulatory peptides are commonly used as tools for examining cellular signaling and tissue-specific regulatory processes. Their defined amino acid sequences make them suitable for controlled experimental studies.
Typical applications include endothelial cell culture experiments, peptide–DNA interaction models, and investigations into molecular pathways associated with vascular signaling. Researchers may also use these peptides to explore how sequence-specific molecules influence gene expression and intracellular communication.
Through these applications, tripeptide regulators provide a simplified platform for studying molecular signaling behavior and sequence-driven regulatory mechanisms.
Solubility and Handling
The peptide is generally supplied as a lyophilized powder, a format that preserves molecular stability and supports long-term storage. Prior to use, the material can be reconstituted using sterile water or compatible laboratory buffers.
Gentle mixing is typically sufficient to achieve complete dissolution. For experimental consistency, researchers often prepare small aliquots after reconstitution to minimize repeated freeze–thaw cycles.
Standard laboratory handling procedures should be followed to maintain peptide stability and ensure reliable experimental results.
Storage
For optimal stability, the lyophilized material is typically stored at −20 °C or lower in a sealed, moisture-protected environment.
After reconstitution, solutions are usually divided into aliquots and stored frozen to reduce degradation caused by repeated temperature changes. Exposure to heat, light, or humidity should be minimized.
When maintained under appropriate laboratory conditions, peptide preparations can remain stable for extended research use.
FAQ
Q: What is Vesugen powder used for?
A: Vesugen powder is a synthetic peptide supplied for laboratory research purposes. It may be applied in biochemical and molecular biology experiments involving peptide-related molecular mechanisms.
Q: What form is the product supplied in?
A: The material is supplied as a white lyophilized peptide powder and can be packaged either as bulk raw powder or laboratory vials.
Q: What is the purity of the peptide?
A: The peptide is manufactured with a purity of not less than 98%, verified using high-performance liquid chromatography (HPLC).
Q: Can the product be customized?
A: Yes. Packaging size, vial format, labeling, and peptide content per vial can be customized according to research requirements.
Q: Is this product intended for human use?
A: No. This product is supplied strictly for laboratory research purposes only and is not intended for human or clinical use.
Hot Tags: vesugen powder, China vesugen powder manufacturers, suppliers, factory, Pancragen Powder, Cortagen Powder, Livagen Powder, Bronchogen Powder, Ovagen Powder, Cardigan Powder
